P-750 A systematic review of vasovasostomy (VV) and vasoepididymostomy (VE) techniques for Vasectomy Reversal: How far have we come?

نویسندگان

چکیده

Abstract Study question A systematic review of current literature evaluating different techniques in performing vasovasostomy (VV) and vasoepididymostomy (VE) including robotic-assisted minimally invasive their outcomes Summary answer Macrosurgical, microsurgical robot-assisted have evidence for use vasectomy reversal. The robotic assistance may benefit over standard techniques. What is known already While a common procedure worldwide, six percent these patients request reversal procedure. Reasons this include change mind, new relationship, death child or wanting more children. sperm harvest combined with in-vitro fertilisation (IVF) an alternative, factors timing patency durability need to be considered prior deciding between harvesting IVF. In 1977, were described by Silber Owen, procedures became following this. differing approaches lacking. design, size, duration was performed using databases Medline PubMed performed, comprising studies 1979 July 30 2022. Systematic articles included. Original on robotic- assisted also Exclusion criteria included animal non-English. Level evaluated. Participants/materials, setting, methods From the eligible identified from above criteria, data extracted used vasoepididymostomy. Surgical pregnancy rates postoperative surgical regarding articles. Data original Main results role chance For vasovasostomy, microscopic mini-incision (MVV), mini incision MVV Moon’s clamp, vasovasostomy. Described surgeons as “most technically challenging procedure”, early approach comprised 3-4cm scrotal delivery testis provide adequate exposure entire epididymis vas deferens. When compared prolonged recovery periods, increased pain swelling identified. comprise end-to end, side, three-suture triangulation intussusception (TIVE), two-suture longitudinal (LIVE), deferential vessel-sparing LIVE, vasoepididymostomy, (RAVE). Retrospective reviews 2-layer anastomosis report rate 85%, similar reports single layer repairs. Microsurgical allow accurate apposition narrow lumen ends, allowing unobstructed semen flow low level suggests high rates. Macrosurgical simple, less expensive quicker alternative. Elzanaty et al. found no clear difference terms vasal patency. Both appeared effective when experienced surgeon. Preliminary reduced morbidity accuracy repair. Limitations, reasons caution With each technique, formal clinical guidelines are not forthcoming. Further evaluation longer follow-up required assess usage true cost-benefit ratio. There standardised measurement tool objective outcome measures compare Wider implications findings This provides available Outcome tools presented, highlighting lack definitions failure. enables determine most effective, efficient cost-effective technique practice. Trial registration number ‘Not applicable'

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Knowledge Representation: How far we have come?

The theory of Knowledge Representation has been one of the central focuses in Artificial Intelligence research over the past 60 years which has seen numerous proposals and debates ranging from very philosophical and theoretical level to practical issues. Although a lot of work has been done in this area, we believe currently, it does not receive enough attention from the research community, exc...

متن کامل

Best Pharmaceuticals for Children: How Far Have We Come?

In response to mounting concerns regarding the safety and efficacy of medications used in pediatric populations, the Best Pharmaceuticals for Children Act (BPCA) was enacted in 2002. The purpose of the BPCA was to promote clinical trials of pharmaceuticals in children that would generate safety and efficacy data. The ultimate goal was pediatric-use approval for more pharmaceuticals and expansio...

متن کامل

Combination Therapy for Multiple Myeloma: How Far Have We Come?

Multiple myeloma (MM) is a malignant neoplasm of plasma cells that constitutes 1% of all cancers and 10% of hematologic neoplasms. MM is the second most common hematologic malignancy after nonHodgkin’s lymphoma. It is estimated that 21,700 new cases of MM (approximately 12,190 men and 9,510 women) will be diagnosed during 2012 in the United States, and approximately 10,710 individuals (6,020 me...

متن کامل

Cell therapies for Parkinson's disease: how far have we come?

Over the past three decades, significant progress has been made in the development of potential regenerative cell-based therapies for neurodegenerative disease, with most success being seen in Parkinson's disease. Cell-based therapies face many challenges including ethical considerations, potential for immune-mediated rejection with allogeneic and xenogeneic tissue, pathological spread of prote...

متن کامل

Endothelial dysfunction and tendinopathy: how far have we come?

Symptomatic tendon tears are one of the most important causes of pain and joint dysfunction. Among the intrinsic causes, vascularization recently gained a major role. Endothelial function is indeed a key factor, as well as vascular tone and thrombotic factors, in the regulation of vascular homeostasis and the composition of vascular wall. In this review, we studied systematically whether there ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Human Reproduction

سال: 2023

ISSN: ['1460-2350', '0268-1161']

DOI: https://doi.org/10.1093/humrep/dead093.1066